<ref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="B116"><label>116</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bikdeli</surname><given-names>B</given-names></name><name><surname>Talasaz</surname><given-names>AH</given-names></name><name><surname>Rashidi</surname><given-names>F</given-names></name><name><surname>Bakhshandeh</surname><given-names>H</given-names></name><name><surname>Rafiee</surname><given-names>F</given-names></name><name><surname>Rezaeifar</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-day results from the INSPIRATION randomized trial</article-title>. <source>Thromb Haemost</source>. (<year>2022</year>) <volume>122</volume>:<page-range>131&#8211;41</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1055/a-1485-2372</pub-id>, PMID: <?supplied-pmid 33865239?><pub-id pub-id-type="pmid">33865239</pub-id>
</mixed-citation></ref>